A Cozzi Lepri
Overview
Explore the profile of A Cozzi Lepri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miltz A, Rodger A, Lepri A, Sewell J, Nwokolo N, Allan S, et al.
AIDS Behav
. 2019 Nov;
24(6):1793-1806.
PMID: 31782068
The aim of this study is to investigate five hypothesized mechanisms of causation between depression and condomless sex with ≥ 2 partners (CLS2+) among gay, bisexual, and other men who...
2.
The identification of pathogens associated with periprosthetic joint infection in two-stage revision
Lepri A, Del Prete A, Soderi S, Innocenti M, Civinini R
Eur Rev Med Pharmacol Sci
. 2019 Apr;
23(2 Suppl):101-116.
PMID: 30977877
Objective: Identification of periprosthetic joint infection (PJI)-related pathogens is crucial to decide what is the correct surgical strategies and the most secure timing to re-implant in case of two-stage revision....
3.
Rezza G, DEgidio P, Lepri A, Costantini D, Petrucci A, Pezzotti P
Addict Biol
. 2016 Jan;
2(2):201-6.
PMID: 26735637
A series of 716 HIV-negative IDUs entering a large drug treatment centre in central Italy was studied to evaluate the pattern of T-lymphocyte subsets among IDUs and to determine the...
4.
Da Cunha-Bang C, Kirkby N, Sonderholm M, Sorensen S, Sengelov H, Iversen M, et al.
Am J Transplant
. 2013 Jan;
13(2):458-66.
PMID: 23282281
(Val)ganciclovir is used to treat cytomegalovirus (CMV) infection following solid organ (SOT) or hematopoietic stem cell (HSCT) transplantation. Treatment failures occur, but the contribution from 39 known ganciclovir-related mutations (GRMs)...
5.
Tordato F, Lepri A, Cicconi P, De Luca A, Antinori A, Colangeli V, et al.
HIV Med
. 2010 Jun;
12(1):4-13.
PMID: 20584091
Background: The prevalence and factors associated with an increased risk of renal dysfunction in HIV-infected patients receiving or not receiving antiretroviral therapy (ART) have been poorly evaluated in observational settings....
6.
Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Lepri A, et al.
Infection
. 2009 Aug;
37(5):445-9.
PMID: 19669092
Background: An evaluation of the prevalence of occult hepatitis B virus (HBV) infection in HIV-positive individuals is important as HBV infection may have an impact on the outcome of the...
7.
Phillips A, Miller V, Sabin C, Lepri A, Klauke S, Bickel M, et al.
AIDS
. 2001 Dec;
15(18):2379-84.
PMID: 11740188
Background: Relatively little is known about the long-term durability of viral suppression in individuals initially achieving a viral load of less than 50 copies/ml within 24 weeks of starting antiretroviral...
8.
Lepri A, Phillips A, dArminio Monforte A, Castelli F, Antinori A, De Luca A, et al.
AIDS
. 2001 Jun;
15(8):983-90.
PMID: 11399980
Objectives: To compare the response to highly active antiretroviral therapy (HAART) in individuals starting HAART at different CD4 cell counts. Design: The mean increase in CD4 cell count and rate...
9.
Lepri A, Sabin C, Staszewski S, Hertogs K, Muller A, Rabenau H, et al.
J Infect Dis
. 2000 Mar;
181(3):1143-7.
PMID: 10720543
The prevalence of phenotypic drug resistance was assessed in 60 patients with a viral rebound after they received a protease inhibitor (PI)- or nonnucleoside reverse transcriptase inhibitor (NNRTI)-containing regimen (baseline)....
10.
Sondergaard S, Lepri A, Ullum H, Wiis J, Hermann C, Laursen S, et al.
Clin Exp Immunol
. 1999 Dec;
119(1):115-22.
PMID: 10606972
The present study aimed to investigate lymphocyte mobilization from peripheral cell reservoirs in HIV-infected patients. Nine HIV-infected patients on stable highly active anti-retroviral therapy (HAART), eight treatment-naive HIV-infected patients and...